Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Big Pharma Split Corp Class A

Financial Services CA PRM

13.4CAD
-0.1(0.74%)

Last update at 2026-06-03T19:45:00Z

Day Range

13.4013.40
LowHigh

52 Week Range

9.8815.39
LowHigh

Fundamentals

  • Previous Close 13.50
  • Market Cap16.83M
  • Volume1107
  • P/E Ratio-
  • Dividend Yield8.68%
  • Revenue TTM5.11M
  • Revenue Per Share TTM4.17
  • Gross Profit TTM 5.11M
  • Diluted EPS TTM-1.95

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 4.40M -0.53862M -0.64535M 3.15M 4.85M
Minority interest - - - - -
Net income 4.40M -0.53862M -0.13968M 3.15M 4.85M
Selling general administrative 0.75M 0.54M 0.33M 0.36M 0.37M
Selling and marketing expenses - - - - -
Gross profit 1.14M 1.53M 0.31M 3.71M 5.36M
Reconciled depreciation - - - - -
Ebit - - -0.50080M - 4.61M
Ebitda 5.03M 0.02M -0.13756M 3.15M 4.85M
Depreciation and amortization - - 0.36M - -
Non operating income net other - - - - -
Operating income 5.03M 0.01M -0.13968M 3.15M 4.85M
Other operating expenses 3.58M 1.84M 0.45M 0.57M 0.51M
Interest expense 0.64M 0.56M 0.51M - 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - -0.50567M - -
Total revenue 1.45M 1.85M 0.31M 3.71M 5.36M
Total operating expenses -3.88971M 0.54M 0.45M 0.57M 0.51M
Cost of revenue 0.31M 0.32M 0.31M - -
Total other income expense net -0.62914M -0.55203M -0.50567M - -
Discontinued operations - - - - -
Net income from continuing ops - 0.01M -0.13968M 3.15M 4.85M
Net income applicable to common shares 4.40M -0.53862M -0.64535M - 4.21M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 31.84M 26.30M 26.53M 39.10M 37.81M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - -26.30195M 0.72M - 0.81M
Total liab 13.57M 12.62M 0.25M 19.37M 15.41M
Total stockholder equity 18.27M 13.68M 15.85M 19.73M 22.40M
Deferred long term liab - - - - -
Other current liab 0.30M -11.57338M -0.24868M -0.34784M -0.33902M
Common stock 18.27M - 15.85M - 22.40M
Capital stock - - - - -
Retained earnings - - - - -
Other liab - - - - -
Good will - - - - -
Other assets - 26.30M - - 0.15M
Cash 1.35M 1.03M 0.20M 0.82M 1.43M
Cash and equivalents - - - - -
Total current liabilities 13.47M - 0.25M 0.35M 0.34M
Current deferred revenue - - -10.04870M - -
Net debt 11.82M 10.54M 10.09M -0.81921M -1.42982M
Short term debt 13.17M 11.57M 10.30M - -
Short long term debt - - - - -
Short long term debt total 13.17M 11.57M 10.30M - -
Other stockholder equity 18.27M 13.68M - - 22.40M
Property plant equipment - - - - -
Total current assets 31.33M - 0.28M 14.82M 1.53M
Long term investments - - 26.25M 24.27M 36.13M
Net tangible assets - - - - 22.40M
Short term investments 29.87M 25.17M 25.54M - -
Net receivables 0.11M 0.10M 0.08M 14.00M 0.10M
Long term debt - - - - -
Inventory - - -0.71824M - -
Accounts payable - - 0.25M 0.35M 0.34M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - -26.25326M -24.27309M -36.13086M
Deferred long term asset charges - - - - -
Non current assets total 0.51M - 26.25M 24.27M 36.13M
Capital lease obligations - - - - -
Long term debt total 0.00000M - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - - - -
Change to liabilities - - - - 0.00000M
Total cashflows from investing activities - - - - -
Net borrowings - - - - -
Total cash from financing activities 1.81M -0.34638M -12.47080M -1.73730M 10.19M
Change to operating activities - - - - -0.15429M
Net income 4.40M -0.53862M -0.64535M 2.39M 4.21M
Change in cash 0.32M 0.83M -0.61502M -0.61061M 1.20M
Begin period cash flow 1.03M 0.20M 0.82M 1.43M 0.23M
End period cash flow 1.35M 1.03M 0.20M 0.82M 1.43M
Total cash from operating activities -1.05502M -1.29552M 11.86M 1.13M -9.00036M
Issuance of capital stock - 1.95M 0.45M 0.88M 13.32M
Depreciation - - - - -
Other cashflows from investing activities - - 0.00000M - -
Dividends paid 1.51M -1.50378M -2.10858M 2.62M 2.84M
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock 3.34M -0.46912M -5.32207M - -
Other cashflows from financing activities -0.02726M -0.00875M -4.59503M 0.48M 5.46M
Change to netincome - - - - -13.05582M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.03214M -0.01248M 0.00966M 0.18M -0.15429M
Stock based compensation - - - - -
Other non cash items -5.42339M -0.74442M 12.49M -1.43645M -13.05582M
Free cash flow -1.05502M -1.29552M 11.86M 1.13M -9.00036M

Peer Comparison

Sector: Financial Services Industry: Asset Management

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PRM
Big Pharma Split Corp Class A		 -0.1 0.74% 13.40 - - 6.28 1.07 6.67 -2.4541
BLK
BlackRock CDR (CAD Hedged)		 -0.86 3.28% 25.37 25.23 18.90 6.38 2.79 6.35 17.13
BN
Brookfield Corporation		 -2.18 3.45% 60.94 94.76 11.96 1.84 2.36 4.58 10.80
BAM
Brookfield Asset Management Ltd		 -3.27 4.95% 62.85 31.22 25.51 22.40 9.70 17.61 25.08
PHYS
Sprott Physical Gold Trust		 -0.31 0.66% 46.62 3.81 - 3.47 1.06 4.09 0.66

Reports Covered

Stock Research & News

View All

Profile

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Big Pharma Split Corp Class A

610 Chartwell Road, Oakville, ON, Canada, L6j 4A5

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.